- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
AMO unveils cataract suite
Abbott Medical Optics has introduced a new system (Micro-Implantation Cataract Suite) designed to help improve cataract procedure outcomes and safety.
Abbott Park, IL- Abbott Medical Optics (AMO) has introduced a new system (Micro-Implantation Cataract Suite) designed to help improve cataract procedure outcomes and safety.
According to the company, the system enables the surgeon to perform an entire microsurgical procedure. Microsurgery can reduce surgically induced astigmatism, provide a safer intraoperative environment, and promote faster healing and visual recovery, according to the company.
The system consists of five separate components, each designed to maximize the benefits of the micro-implantation procedure:
• An implantation system (Unfolder Platinum 1 Series)
• IOLs (Tecnis 1-Piece)
• Viscoelastic (Healon) clear ophthalmic viscosurgical device
• A phacoemulsification system (Whitestar Signature)
• Surgical accessories designed specifically for microsurgery procedures
